These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2427139

  • 1. On the identity of vitronectin and S-protein: immunological crossreactivity and functional studies.
    Tomasini BR, Mosher DF.
    Blood; 1986 Sep; 68(3):737-42. PubMed ID: 2427139
    [Abstract] [Full Text] [Related]

  • 2. Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation.
    Conlan MG, Tomasini BR, Schultz RL, Mosher DF.
    Blood; 1988 Jul; 72(1):185-90. PubMed ID: 2455567
    [Abstract] [Full Text] [Related]

  • 3. Physicochemical, immunochemical and functional comparison of human S-protein and vitronectin. Evidence for the identity of both plasma proteins.
    Preissner KT, Heimburger N, Anders E, Müller-Berghaus G.
    Biochem Biophys Res Commun; 1986 Jan 29; 134(2):951-6. PubMed ID: 2418831
    [Abstract] [Full Text] [Related]

  • 4. Association of thrombin-antithrombin III complex with vitronectin in serum.
    Ill CR, Ruoslahti E.
    J Biol Chem; 1985 Dec 15; 260(29):15610-5. PubMed ID: 2415521
    [Abstract] [Full Text] [Related]

  • 5. Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea.
    Tomasini BR, Mosher DF.
    Blood; 1988 Sep 15; 72(3):903-12. PubMed ID: 2458152
    [Abstract] [Full Text] [Related]

  • 6. Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectin.
    Lane DA, Flynn AM, Pejler G, Lindahl U, Choay J, Preissner K.
    J Biol Chem; 1987 Dec 05; 262(34):16343-8. PubMed ID: 2445746
    [Abstract] [Full Text] [Related]

  • 7. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin.
    Preissner KT, Müller-Berghaus G.
    J Biol Chem; 1987 Sep 05; 262(25):12247-53. PubMed ID: 2442161
    [Abstract] [Full Text] [Related]

  • 8. Serum spreading factor (vitronectin) is present at the cell surface and in tissues.
    Hayman EG, Pierschbacher MD, Ohgren Y, Ruoslahti E.
    Proc Natl Acad Sci U S A; 1983 Jul 05; 80(13):4003-7. PubMed ID: 6191326
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
    Declerck PJ, De Mol M, Alessi MC, Baudner S, Pâques EP, Preissner KT, Müller-Berghaus G, Collen D.
    J Biol Chem; 1988 Oct 25; 263(30):15454-61. PubMed ID: 2459123
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin.
    de Boer HC, Preissner KT, Bouma BN, de Groot PG.
    J Biol Chem; 1992 Feb 05; 267(4):2264-8. PubMed ID: 1370815
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylation of vitronectin by a protein kinase in human plasma. Identification of a unique phosphorylation site in the heparin-binding domain.
    McGuire EA, Peacock ME, Inhorn RC, Siegel NR, Tollefsen DM.
    J Biol Chem; 1988 Feb 05; 263(4):1942-5. PubMed ID: 2448300
    [Abstract] [Full Text] [Related]

  • 14. Novel purification of vitronectin from human plasma by heparin affinity chromatography.
    Yatohgo T, Izumi M, Kashiwagi H, Hayashi M.
    Cell Struct Funct; 1988 Aug 05; 13(4):281-92. PubMed ID: 2460263
    [Abstract] [Full Text] [Related]

  • 15. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
    Tschopp J, Masson D, Schäfer S, Peitsch M, Preissner KT.
    Biochemistry; 1988 May 31; 27(11):4103-9. PubMed ID: 2458130
    [Abstract] [Full Text] [Related]

  • 16. Isolation and characterization of a platelet membrane protein related to the vitronectin receptor.
    Lam SC, Plow EF, D'Souza SE, Cheresh DA, Frelinger AL, Ginsberg MH.
    J Biol Chem; 1989 Mar 05; 264(7):3742-9. PubMed ID: 2465293
    [Abstract] [Full Text] [Related]

  • 17. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
    Ehrlich HJ, Gebbink RK, Keijer J, Linders M, Preissner KT, Pannekoek H.
    J Biol Chem; 1990 Aug 05; 265(22):13029-35. PubMed ID: 1695900
    [Abstract] [Full Text] [Related]

  • 18. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L, Morris CA, Sheehan MC, Charlesworth JA, Pussell BA.
    Clin Exp Immunol; 1993 Apr 05; 92(1):114-9. PubMed ID: 7682159
    [Abstract] [Full Text] [Related]

  • 19. Localization of vitronectin (S-protein of complement) in normal human skin.
    Dahlbäck K, Löfberg H, Dahlbäck B.
    Acta Derm Venereol; 1986 Apr 05; 66(6):461-7. PubMed ID: 2433863
    [Abstract] [Full Text] [Related]

  • 20. Ternary vitronectin-thrombin-antithrombin III complexes in human plasma. Detection and mode of association.
    de Boer HC, de Groot PG, Bouma BN, Preissner KT.
    J Biol Chem; 1993 Jan 15; 268(2):1279-83. PubMed ID: 7678252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.